Jason Karp – From Hedge Funds to Health and Wellness at HumanCo (First Meeting, EP.12)

Episode Summary

Executive Summary: Jason Karp traces his shift from quant hedge fund investing to mission-driven consumer ventures, arguing that judgment, process, and duration matter more than short-term market cleverness in today’s commoditized hedge fund world. After a health crisis reshaped his life, he founded HumanCo to back cleaner consumables, using data, AI, and a holding-company structure to build trusted brands in food, wellness, and cannabis.

Main Topics: Career arc from quant to fundamental investing (Priority: 5/5): Karp explains how early work in quantitative hedge funds taught him probabilistic thinking, but he later moved toward fundamentals because human judgment, emotional discipline, and repeatable decision-making were his real edge. Decision-making frameworks: checklists, poker, chess (Priority: 5/5): He details how poker and chess shaped his approach to investing, emphasizing process over outcome, positioning for uncertainty, and building systems that reduce bias and self-sabotage. Hedge fund industry skepticism (Priority: 5/5): Karp argues the industry is far more competitive and commoditized than in the past, with most returns now resembling beta and fewer durable alpha opportunities unless managers have exceptional skill and the right structure. Health crisis and personal transformation (Priority: 5/5): A serious autoimmune and eye-disease episode, compounded by depression, led Karp to adopt a radically cleaner lifestyle and redefine health as the foundation of performance and happiness. HumanCo’s mission and structure (Priority: 5/5): He describes HumanCo as a Berkshire-like holding company focused on healthier living, aiming to acquire, incubate, and scale consumable businesses that use clean ingredients and restore consumer trust. Data, AI, and operating leverage in consumer brands (Priority: 4/5): HumanCo uses data science to identify trends, source companies, and optimize inventory/reordering, and Karp argues the holding-company model can create real synergies across marketing, sales, and operations. Cannabis and safer vaporization (Priority: 4/5): Karp highlights cannabis vaporization as an example of a neglected category where cleaner, more trustworthy products and tighter provenance controls can improve safety and trust.

Key Arguments: Quant methods are useful, but durable edge comes from human judgment, discipline, and process; markets arbitrage away many purely discoverable signals. Checklists and repeatable systems help investors avoid bias and self-sabotage, making process more important than short-term results. Poker and chess are useful analogies for investing because they teach probability, position, optionality, and acceptance of uncertainty. The hedge fund industry has become hyper-competitive, with much of the easy alpha gone and many strategies now better thought of as beta in disguise. Many managers are in the wrong structure: to succeed today, they need longer duration, more patience, and alignment with how opportunities actually arise. Health is the most important determinant of life quality; Karp’s own illness convinced him that food, sleep, exercise, and lifestyle can materially change outcomes. Large consumer companies have eroded trust by optimizing for shelf life and profitability, creating an opening for cleaner, trusted brands. A holding-company model can outperform VC-style fragmentation by sharing resources, data, and capabilities across related businesses. Data and AI can improve both deal sourcing and operating performance, including trend detection and reordering optimization. Cannabis offers a clear example of a category where product safety, provenance, and adulterant control matter as much as consumer demand.

Data Points: Years in hedge funds: 20+ years - Karp describes his hedge fund career before founding HumanCo. Age when starting first hedge fund job: 21 - He joined a quantitative hedge fund in New York in 1998. Time in pure quant function: About 4.5 years - He worked as a quant researcher/analyst before moving into hybrid/fundamental investing. Years at first hedge fund employer: About 7 years - He says he spent roughly seven years at the first hedge fund. Years at SAC: About 4 years - He later worked at SAC for around four years. Turbillon launch year: End of 2012 - He founded his own fund, Turbillon Capital, at the end of 2012. Turbillon close/return of capital: End of 2018 - He says he retired from hedge funds and returned all investor money in 2018. Turbillon performance: First 3 years strong, last 3 years weak - He notes early success followed by his only losing stretch in 20 years. Investor outcome at Turbillon: Net made money for all investors - He says early investors overall made money despite later struggles. Corneal disease: Keratoconus - He describes this degenerative eye condition and its impact on vision. Vision-related symptoms duration: 4 to 5 months - He had halos and double vision for several months during illness. Lifestyle reversal timeline: About 9 months - He claims disciplined lifestyle changes reversed symptoms and restored vision. Health crisis onset: About 1.5 years into his first job - He became very sick after beginning work at the hedge fund. Autoimmune struggle duration: More than half his life - He says he has battled autoimmune disease for much of his life and all of adulthood. HumanCo incubation period before outside investors: Over 1 year - He and Ross incubated the idea personally before opening to investors. HumanCo current incubations: 3 companies - He says HumanCo is currently incubating three companies. Current acquisition in term sheet: 1 small company - He mentions being in term sheet to acquire a very small company with a strong product. Team size mentioned: 5 people - He names himself, co-founder Ross Berman, one data scientist, and two other team members implied by the structure discussion. Cannabis investing horizon: About 5 years - He says he has been investing in cannabis for roughly five years. Vaporization heating temperature: About 350°F - He explains vaporizing cannabis flower below combustion temperature. Combustion gap: 50 to 80 degrees below combustion - He contrasts vaporization with lighting cannabis on fire. Health summit dates: October 6–8, 2025 - AlphaSense’s Alpha Summit 2025 in Brooklyn is promoted at the start. AlphaSense source count: Over 500 million premium sources - Promotional mention of AlphaSense’s market intelligence platform. AlphaSense expert calls: Over 200,000 expert calls - Promotional mention of AlphaSense’s content library.

Pivotal Quotes: "almost everything that was discoverable in finance would be arbitraged away, but human judgment would not" — Jason Karp: Explaining why he moved from pure quant work toward judgment-driven investing. "I think opportunities are always going to be there, but I think duration matters much more than it ever has" — Jason Karp: Discussing why many hedge fund managers need a different structure and time horizon. "If you're not healthy, everything else is worthless" — Jason Karp: Summarizing the lesson from his illness and shift toward health and wellness.

Implications: Listeners should view investing, health, and business building through the lens of process, trust, and duration. The episode suggests cleaner consumer brands and data-enabled holding companies may outperform legacy models as consumers demand transparency and better outcomes.